Published in J Immunol on December 15, 2002
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology (2009) 2.22
Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol (2013) 2.16
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A (2004) 1.77
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest (2012) 1.68
Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection. PLoS One (2015) 1.43
Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J Immunol (2010) 1.25
Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun (2006) 1.21
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori. Infect Immun (2003) 1.15
Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun (2005) 1.12
Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol (2013) 1.09
HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine (2011) 1.09
Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun (2003) 1.05
H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell Commun Signal (2011) 1.02
Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun (2010) 1.00
Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. World J Gastroenterol (2007) 0.99
Natural history of gastric mucosal cytokine expression in Helicobacter pylori gastritis in Mongolian gerbils. Infect Immun (2005) 0.98
Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase. Infect Immun (2010) 0.97
Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. Am J Pathol (2009) 0.94
TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. PLoS One (2013) 0.93
Regulation of IL-18 in Helicobacter pylori infection. J Immunol (2008) 0.93
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A. Helicobacter (2011) 0.92
Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection. World J Gastroenterol (2007) 0.92
Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection. MBio (2014) 0.92
Natural killer cells and Helicobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production. Infect Immun (2005) 0.91
A pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis. Gut (2014) 0.90
Helicobacter pylori-pulsed dendritic cells induce H. pylori-specific immunity in mice. Helicobacter (2008) 0.90
Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog (2007) 0.90
Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol (2010) 0.90
Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol (2014) 0.90
Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. PLoS One (2011) 0.89
Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis. Infect Immun (2004) 0.88
Partial protection against Helicobacter pylori in the absence of mast cells in mice. Infect Immun (2009) 0.86
Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun (2007) 0.84
Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization. PLoS One (2013) 0.84
CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice. Clin Exp Immunol (2004) 0.82
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance. J Immunol Res (2015) 0.81
Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol (2009) 0.81
Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection. Infect Immun (2003) 0.81
Vaccinating against Helicobacter pylori in the developing world. Gut Microbes (2013) 0.80
Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection. Clin Vaccine Immunol (2011) 0.79
CagY Is an Immune-Sensitive Regulator of the Helicobacter pylori Type IV Secretion System. Gastroenterology (2016) 0.77
Systematic identification of immunodominant CD4+ T cell responses to HpaA in Helicobacter pylori infected individuals. Oncotarget (2016) 0.77
Oral vaccination against Helicobacter pylori infection is not effective in mice with Fas ligand deficiency. Dig Dis Sci (2005) 0.77
Persistent H. pylori colonization in early acquisition age of mice related with higher gastric sialylated Lewis x, IL-10, but lower interferon-γ expressions. J Biomed Sci (2008) 0.76
Identification and characterization of H-2d restricted CD4+ T cell epitopes on Lpp20 of Helicobacter pylori. BMC Immunol (2012) 0.76
The Immunomodulator VacA Promotes Immune Tolerance and Persistent Helicobacter pylori Infection through Its Activities on T-Cells and Antigen-Presenting Cells. Toxins (Basel) (2016) 0.76
Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey. Lab Anim Res (2016) 0.75
Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice. Sci Rep (2015) 0.75
Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice. PLoS One (2015) 0.75
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05
An analysis of human microRNA and disease associations. PLoS One (2008) 5.21
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis (2011) 3.98
Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. J Med Chem (2006) 2.95
Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis (2004) 2.66
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem (2006) 2.35
MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med (2013) 2.31
Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients. Biol Psychiatry (2013) 2.30
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog (2011) 2.15
Structure-based design of potent non-peptide MDM2 inhibitors. J Am Chem Soc (2005) 2.12
Amino acid conjugated sophorolipids: A new family of biologically active functionalized glycolipids. Bioconjug Chem (2006) 2.01
Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol (2006) 1.91
Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med (2014) 1.80
Graphene quantum dots derived from carbon fibers. Nano Lett (2012) 1.79
HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Natl Acad Sci U S A (2003) 1.71
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother (2008) 1.66
Nano/Microscale motors: biomedical opportunities and challenges. ACS Nano (2012) 1.61
A new linearized Crank-Nicolson mixed element scheme for the extended Fisher-Kolmogorov equation. ScientificWorldJournal (2013) 1.58
Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia? Crit Care Med (2011) 1.57
The effect of obesity on outcomes in trauma patients: a meta-analysis. Injury (2012) 1.56
Antibiotic-killed Staphylococcus aureus induces destructive arthritis in mice. Arthritis Rheumatol (2015) 1.56
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci U S A (2013) 1.51
Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic. J Med Chem (2006) 1.49
Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation (2003) 1.45
Retracted Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis. Eur J Med Res (2014) 1.45
Overexpression of Arabidopsis acyl-CoA binding protein ACBP3 promotes starvation-induced and age-dependent leaf senescence. Plant Cell (2010) 1.43
Usefulness of lumen area parameters determined by intravascular ultrasound to predict functional significance of intermediate coronary artery stenosis. Chin Med J (Engl) (2013) 1.42
Feasibility of using a liver infected with Clonorchis sinensis for liver transplantation: fourteen cases. Liver Transpl (2010) 1.40
CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. Vaccine (2008) 1.38
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2013) 1.38
Gastric outlet obstruction caused by heterotopic pancreas: A case report and a quick review. World J Gastroenterol (2008) 1.37
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. J Hepatol (2007) 1.36
Improved design and intranasal delivery of an M2e-based human influenza A vaccine. Vaccine (2006) 1.32
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine (2005) 1.31
Modular pathway engineering of diterpenoid synthases and the mevalonic acid pathway for miltiradiene production. J Am Chem Soc (2012) 1.30
Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Med Oncol (2014) 1.25
Prox1 is a novel coregulator of Ff1b and is involved in the embryonic development of the zebra fish interrenal primordium. Mol Cell Biol (2003) 1.24
Paintable battery. Sci Rep (2012) 1.23
HIV-1 drug resistance in variants from the female genital tract and plasma. J Infect Dis (2007) 1.20
Lithospheric structure of the Rio Grande rift. Nature (2005) 1.20
A computational model to define the molecular causes of type 2 diabetes mellitus. Diabetes Technol Ther (2005) 1.19
Overexpression of membrane-associated acyl-CoA-binding protein ACBP1 enhances lead tolerance in Arabidopsis. Plant J (2008) 1.19
A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction. Nat Neurosci (2012) 1.18
Altered structural connectivity in neonates at genetic risk for schizophrenia: a combined study using morphological and white matter networks. Neuroimage (2012) 1.18
Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2008) 1.17
Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J Immunol (2004) 1.16
The novel presenilin-1-associated protein is a proapoptotic mitochondrial protein. J Biol Chem (2002) 1.15
Short-form Zarit Caregiver Burden Interviews were valid in advanced conditions. J Clin Epidemiol (2010) 1.15
The posterolateral shearing tibial plateau fracture: treatment and results via a modified posterolateral approach. Knee (2008) 1.13
Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol (2010) 1.13
Cortisol in hair, body mass index and stress-related measures. Biol Psychol (2012) 1.12
Hysteresis modeling of magnetic shape memory alloy actuator based on Krasnosel'skii-Pokrovskii model. ScientificWorldJournal (2013) 1.11
Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study. Clin Chem (2012) 1.11
cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I. J Neurosci (2008) 1.10
Screening for genes essential for mouse embryonic stem cell self-renewal using a subtractive RNA interference library. Stem Cells (2006) 1.10
Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. J Antimicrob Chemother (2011) 1.10
Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J Exp Med (2002) 1.10
Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol (2005) 1.08
Combining metabolomics and transcriptomics to characterize tanshinone biosynthesis in Salvia miltiorrhiza. BMC Genomics (2014) 1.08
Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol (2004) 1.08
FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett (2013) 1.08
Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr (2011) 1.08
Mir-24 regulates junctophilin-2 expression in cardiomyocytes. Circ Res (2012) 1.07
Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction. BMC Cardiovasc Disord (2010) 1.07
[(E)-10-(2,6-Dimethyl-phenyl-imino)-9-methyl-9,10-dihydro-phenanthren-9-olato]penta-methyl-dialuminum(III). Acta Crystallogr Sect E Struct Rep Online (2011) 1.07
In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice. Circ Res (2013) 1.07
In situ high-temperature crystallographic evolution of a nonstoichiometric Li2O·2SiO2 glass. Inorg Chem (2013) 1.07
Analysis of genetic diversity in Ganoderma population with a novel molecular marker SRAP. Appl Microbiol Biotechnol (2006) 1.07
Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry'. Bioorg Med Chem Lett (2007) 1.07
Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. J Med Chem (2006) 1.06
Regression Models for Identifying Noise Sources in Magnetic Resonance Images. J Am Stat Assoc (2009) 1.06
Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes (2014) 1.06
Micromotor-based lab-on-chip immunoassays. Nanoscale (2013) 1.06
Psychological well-being and quality of care: a factor-analytic examination of the palliative care outcome scale. J Pain Symptom Manage (2010) 1.05
Improving image segmentation performance and quantitative analysis via a computer-aided grading methodology for optical coherence tomography retinal image analysis. J Biomed Opt (2010) 1.05
Sphingosine 1-phosphate modulates spinal nociceptive processing. J Biol Chem (2008) 1.04
Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins. J Med Chem (2007) 1.04
Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. J Gastroenterol (2012) 1.04
Bimetallic anilido-aldimine Al or Zn complexes for efficient ring-opening polymerization of epsilon-caprolactone. Dalton Trans (2008) 1.04
Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis. J Mol Biol (2006) 1.04
Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI. Neuroimage (2011) 1.04
Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev (2013) 1.03
Heterosynaptic long-term depression mediated by ATP released from astrocytes. Glia (2012) 1.03
Skin cancer incidence is highly associated with ultraviolet-B radiation history. Int J Hyg Environ Health (2010) 1.03
Ultrastructural uncoupling between T-tubules and sarcoplasmic reticulum in human heart failure. Cardiovasc Res (2013) 1.03
Reversal of English trend towards hospital death in dementia: a population-based study of place of death and associated individual and regional factors, 2001-2010. BMC Neurol (2014) 1.03
Priorities for treatment, care and information if faced with serious illness: a comparative population-based survey in seven European countries. Palliat Med (2013) 1.02
Characterization of the gas sensors based on polymer-coated resonant microcantilevers for the detection of volatile organic compounds. Anal Chim Acta (2010) 1.02
Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis. World J Gastroenterol (2003) 1.02
Bacterial isolation by lectin-modified microengines. Nano Lett (2011) 1.01
Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol (2009) 1.01
A unique population of extrathymically derived alpha beta TCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tract. J Immunol (2003) 1.01
Caregiver assessment of patients with advanced cancer: concordance with patients, effect of burden and positivity. Health Qual Life Outcomes (2008) 1.00
Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside. Biomarkers (2011) 0.99